| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/10/2000 | CN1052231C 2-oxo-5-oxazolidone methyl compound their preparing method and medicinal composition containing them |
| 05/10/2000 | CN1052227C Oxazolidone used as adhesive receptor antagenists, its preparing method and medicinal composition containing them |
| 05/10/2000 | CN1052162C Production method of traditional Chinese medicine pills for hyperostosis |
| 05/10/2000 | CN1052161C Medicine for curing bone tuberculosis and osteomyelitis |
| 05/09/2000 | US6060475 Substituted pyrazin-2-yl-sulphonamide-(3-pyridyl) compounds and uses thereof |
| 05/09/2000 | US6060061 Method for preventing or treating disorders involving an inflammatory process |
| 05/09/2000 | CA2112239C Enantiomeric hydroxylated xanthine compounds |
| 05/04/2000 | WO2000024911A2 Human phospholipases |
| 05/04/2000 | WO2000024897A1 Cell surface molecule-induced macrophage activation |
| 05/04/2000 | WO2000024886A1 Prv-1 gene and the use thereof |
| 05/04/2000 | WO2000024782A2 Modified peptides, comprising an fc domain, as therapeutic agents |
| 05/04/2000 | WO2000024771A2 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same |
| 05/04/2000 | WO2000024764A1 Lhrh analogues for the treatment of osteoporosis |
| 05/04/2000 | WO2000024742A1 Pyrazolopyridine as adenosine antagonists |
| 05/04/2000 | WO2000024724A1 Thiazole-derivatives |
| 05/04/2000 | WO2000024719A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 05/04/2000 | WO2000024707A1 Substituted phenyl derivatives, their preparation and use |
| 05/04/2000 | WO2000024416A1 Remedies for bone metabolic errors |
| 05/04/2000 | WO2000024403A1 Use of antifungal agents for treating scleroses |
| 05/04/2000 | WO2000024402A1 Use of antifungal agents for treating scleroses |
| 05/04/2000 | WO2000024398A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues |
| 05/04/2000 | WO2000024393A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| 05/04/2000 | WO2000006730A3 Human cytoskeletal proteins |
| 05/04/2000 | WO2000006254A3 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 05/04/2000 | WO2000006187A3 Modulation of apoptosis |
| 05/04/2000 | WO2000006085A3 Compounds and methods |
| 05/04/2000 | WO2000004868A3 Libraries of polyhydroxamates and their analogs |
| 05/04/2000 | WO1999043672A9 Inhibitors of phospholipase a2 |
| 05/04/2000 | DE19850131A1 Chromenon- und Chromanonderivate Chromenon- and chromanone |
| 05/04/2000 | DE19850072A1 Phosphinat-Peptidanaloga zur Behandlung von fibrotischen Erkrankungen Phosphinate-peptide analogues in the treatment of fibrotic diseases |
| 05/04/2000 | CA2349211A1 Prv-1 gene and the use thereof |
| 05/04/2000 | CA2348833A1 Human phospholipases |
| 05/04/2000 | CA2348160A1 Use of antifungal agents for treating scleroses |
| 05/04/2000 | CA2348023A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues |
| 05/04/2000 | CA2347982A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 05/04/2000 | CA2347365A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| 05/04/2000 | CA2347293A1 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same |
| 05/04/2000 | CA2347107A1 Bone-pathobolism treating agent |
| 05/04/2000 | CA2342626A1 Substituted phenyl derivatives, their preparation and use |
| 05/03/2000 | EP0996731A2 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 05/03/2000 | EP0996448A1 Treatment and prevention of adhesions |
| 05/03/2000 | EP0996446A1 Novel substituted imidazole compounds |
| 05/03/2000 | EP0563096B1 Novel methylenebisphosphonic acid derivatives |
| 05/03/2000 | CN1252064A Bicyclic amino acids |
| 05/02/2000 | US6057369 Use in the treatment of disease states associated with proteins that mediate cellular activity which are capable of being modulated by inhibiting a matrix metalloproteinase (mmp), tumor necrosis factor (tnf) or cyclic amp |
| 05/02/2000 | US6057362 Protease inhibitors |
| 05/02/2000 | US6057336 Lactam metalloprotease inhibitors |
| 05/02/2000 | US6057294 Peptide |
| 05/02/2000 | US6057122 Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis |
| 05/02/2000 | US6055936 Sea cucumber carotenoid lipid fractions and process |
| 05/02/2000 | CA2169362C Formulations for delivery of osteogenic proteins |
| 04/27/2000 | WO2000023618A1 Polymorphism in a tgf-beta gene correlated to osteoporosis |
| 04/27/2000 | WO2000023594A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
| 04/27/2000 | WO2000023572A1 Tnfr related gene 12 |
| 04/27/2000 | WO2000023457A1 Adenine derivatives |
| 04/27/2000 | WO2000023451A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023445A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023433A1 Substituted benzopyran analogs for the treatment of inflammation |
| 04/27/2000 | WO2000023430A1 Substituted thiadiazolsulfonamides used as interleukin-1-beta inhibitors |
| 04/27/2000 | WO2000023425A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023417A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023416A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023415A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023113A1 Peptide-based carrier devices for stellate cells |
| 04/27/2000 | WO2000023093A1 Compositions and methods for promoting tissue repair using heat shock proteins |
| 04/27/2000 | WO2000023091A2 Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases |
| 04/27/2000 | WO2000023078A1 Pharmaceutical compositions containing tetrahydroisoquinoline compounds |
| 04/27/2000 | WO2000023068A2 Fumaric acid microtablets |
| 04/27/2000 | WO2000023053A2 Artificial antigen-specific cells and related methods |
| 04/27/2000 | DE19849044A1 New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies |
| 04/27/2000 | DE19845286A1 New carrier material coated with specific antibodies, used to remove tumor necrosis factor and other disease-associated compounds from blood, for treating arthritis or pyelonephritis |
| 04/27/2000 | CA2347910A1 Substituted benzopyran analogs for the treatment of inflammation |
| 04/27/2000 | CA2347204A1 Compositions and methods for promoting tissue repair using heat shock proteins |
| 04/27/2000 | CA2347080A1 Tnfr related gene 12 |
| 04/27/2000 | CA2346937A1 Specific therapeutic interventions obtained by interference with redistribution and/or targeting |
| 04/27/2000 | CA2345938A1 Polymorphism in a tgf-beta gene correlated to osteoporosis |
| 04/26/2000 | EP0995445A2 Ligand-mediated immunofunctional hormone binding protein assay method |
| 04/26/2000 | EP0994884A1 Diphosphonic acid salts for the treatment of osteoporosis |
| 04/26/2000 | EP0994876A1 Quaternary ammonium compounds as tachykinin antagonists |
| 04/26/2000 | EP0994870A1 Novel aryloxy substituted pyrimidine imidazole compounds |
| 04/26/2000 | EP0994858A1 2-substituted imidazoles useful in the treatment of inflammatory diseases |
| 04/26/2000 | EP0994853A2 Compounds and methods for the inhibition of the expression of vcam-1 |
| 04/26/2000 | EP0994717A1 Treatment of autoimmune disease using tolerization in combination with methotrexate |
| 04/26/2000 | EP0994708A1 Antagonists of gonadotropin releasing hormone |
| 04/26/2000 | EP0994704A1 Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases |
| 04/26/2000 | EP0760598A4 Meniscal augmentation device |
| 04/26/2000 | EP0554381B2 Use of protective agents against reactive oxygen species |
| 04/26/2000 | CN1251530A Use of substaces having oxytocin activity for preparation of medicaments for wound healing |
| 04/26/2000 | CN1251522A Antirheumatic agents |
| 04/26/2000 | CN1251310A Chinese medicine for treating hyperosteogeny, arthritis and herniation of cervical disc and prolapse of lumbar intervertebral disc and administration device thereof |
| 04/26/2000 | CN1051769C Parathyroid hormone analogues, their production method and medicinal composition containing same |
| 04/26/2000 | CN1051705C Composition comprising tramadol material and any of codeine, oxycodone or hydrocodone and their use thereof |
| 04/25/2000 | US6054470 Src family SH2 domain inhibitors |
| 04/25/2000 | US6054446 17-substituted-17-desoxy-1,3,5-estratrienes. |
| 04/20/2000 | WO2000022143A2 Protein kinase homologs |
| 04/20/2000 | WO2000022142A2 Cell signaling polypeptides and nucleic acids |
| 04/20/2000 | WO2000022126A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | WO2000021998A1 Bone morphogenetic protein antagonist based on the mature protein |
| 04/20/2000 | WO2000021986A2 Matrix-remodeling genes |
| 04/20/2000 | WO2000021976A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |